Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin D and Reduced Oxidative Stress

Research synthesisLow evidenceMixed effect size3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects of vitamin D on reducing oxidative stress, with effect sizes ranging from small to large. One high-quality clinical trial in multiple sclerosis patients found large reductions using 50,000 IU/week for 8 weeks (median study duration 56 days). Effects were also observed in healthy adults, though one study used a multi-ingredient probiotic blend, limiting attribution to vitamin D alone.

  • Studied populations: multiple sclerosis patients, generally healthy adults

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 3 studies) — conclusions should be considered preliminary. One of the clinical trials tested vitamin D in combination with a probiotic, not as a standalone intervention. Only one study reported a specific dose and duration, limiting dose-response conclusions.

Generated Jul 12, 2026
Doses used in studies
  • IU/week: 50,000 (median 50,000, IQR 50,00050,000) 1 study
Time to effect
Median: 8 weeks · IQR 8 weeks8 weeks · Range 8 weeks8 weeks — Reported in 1 of 3 studies
Safety in these studies
  • Overall tolerabilityReported

    The neuroprotective role of vitamin D suggests the potential benefit of vitamin supplementation in slowing the progression of such conditions and promoting brain health.

    from: Vitamin D and Brain Health.
3 of 3 papers
Back to top